Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-077473
Filing Date
2022-07-05
Accepted
2022-07-05 21:04:11
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220442-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2220442-1_4seq1.xml 4 4029
  Complete submission text file 0001104659-22-077473.txt   5604
Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN 4 L2
Business Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN 4 L2 6504963552
MILLER MICHAEL PATRICK (Reporting) CIK: 0001236514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 221067211

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations